TY - JOUR
T1 - Subcutaneous-Insulin-Resistance Syndrome
AU - Chalmers, Thomas C.
AU - Richter, Werner O.
AU - Schwandt, Peter
AU - White, Neil H.
AU - Santiago, Julio V.
AU - Dandona, P.
AU - Fonseca, V.
AU - Beckett, A. G.
AU - Schade, David S.
AU - Duckworth, William C.
PY - 1987/1/1
Y1 - 1987/1/1
N2 - To the Editor: It is probable that every aging investigator has had the same experience, but it is frustrating to find that a current article in the Journal (July 17 issue)1 fails to mention important original work on the same topic. Twenty-seven years ago, Moore, Mitchell, and I2 studied the absorption of subcutaneously and intramuscularly injected 131I-labeled insulin, by direct measurement over the injection site. At the time, apparently no one else had studied this topic in such a direct way. Although the paper was written before we began to appreciate the implications of the Type II (beta) error, we.
AB - To the Editor: It is probable that every aging investigator has had the same experience, but it is frustrating to find that a current article in the Journal (July 17 issue)1 fails to mention important original work on the same topic. Twenty-seven years ago, Moore, Mitchell, and I2 studied the absorption of subcutaneously and intramuscularly injected 131I-labeled insulin, by direct measurement over the injection site. At the time, apparently no one else had studied this topic in such a direct way. Although the paper was written before we began to appreciate the implications of the Type II (beta) error, we.
UR - http://www.scopus.com/inward/record.url?scp=0023112483&partnerID=8YFLogxK
U2 - 10.1056/NEJM198701013160112
DO - 10.1056/NEJM198701013160112
M3 - Letter
C2 - 3537795
AN - SCOPUS:0023112483
SN - 0028-4793
VL - 316
SP - 49
EP - 51
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 1
ER -